FCGR1A Protein - Fc Gamma Receptor IA
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FCGR1A Protein - Fc Gamma Receptor IA</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>FCGR1A (FcγRI)</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>FCGR1A</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P12314</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>40-45 kDa (glycosylated)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Plasma membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Fc gamma receptor family</td>
</tr>
<tr>
<td class="label">Structure</td>
<td>Type I transmembrane glycoprotein</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Phagocytosis</td>
<td>Engulfs IgG-opsonized particles</td>
</tr>
<tr>
<td class="label">ADCC</td>
<td>Kill antibody-coated target cells</td>
</tr>
<tr>
<td class="label">Cytokine release</td>
<td>Activate inflammatory responses</td>
</tr>
<tr>
<td class="label">Antigen presentation</td>
<td>Enhance MHC class II expression</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Description</td>
</tr>
<tr>
<td class="label">FcγRI antagonists</td>
<td>Reduce microglial activation</td>
</tr>
<tr>
<td class="label">Antibody engineering</td>
<td>Modulate effector functions</td>
</tr>
<tr>
<td class="label">IVIg therapy</td>
<td>Compete for receptor binding</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Block receptor signaling</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Fcgr1A Protein Fc Gamma Receptor Ia is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FCGR1A Protein (Fc Gamma Receptor IA, also known as FcγRI) is a high-affinity receptor for immunoglobulin G (IgG) that plays critical roles in immune cell activation and inflammatory responses. This receptor is expressed primarily on monocytes, macrophages, and dendritic cells, where it mediates phagocytosis, antibody-dependent cellular cytotoxicity (ADCC), and cytokine release. In the central nervous system, Fcγ receptors are expressed on [microglia](/cell-types/microglia-neuroinflammation) and play pivotal roles in neuroinflammation, making them relevant targets for neurodegenerative disease research. [@radermecker2020]
Overview
Structure
Extracellular Domain
The extracellular region of FcγRI contains three immunoglobulin-like domains (α1, α2, α3) that form the high-affinity IgG binding site. Unlike other Fcγ receptors, FcγRI binds monomeric IgG with high affinity (Kd ~10⁻⁸ M), enabling it to respond to circulating antibodies rather than requiring immune complexes. The receptor exhibits species-specific binding preferences, with different affinities for mouse versus human IgG subclasses.
Transmembrane Domain
A single-pass α-helix anchors the receptor in the plasma membrane, providing a stable signal sequence for membrane insertion and proper orientation of the extracellular and cytoplasmic domains.
Cytoplasmic Tail
The cytoplasmic tail contains an Immunoreceptor Tyrosine-based Activation Motif (ITAM) that links receptor engagement to intracellular signaling cascades including SYK, PI3K, and MAPK pathways.
Normal Function
Immune Functions
FcγRI serves multiple critical immune functions:
CNS Functions
Within the central nervous system, microglial FcγRI plays important roles:
- Engulfment of antibody-bound pathogens and debris
- Potential clearance of [amyloid-beta](/proteins/amyloid-beta) plaques in AD
- Activation of neuroinflammatory responses
- Regulation of synaptic pruning during development
Role in Disease
Alzheimer's Disease
FcγRI on microglia contributes to Alzheimer's disease pathology through multiple mechanisms:
- Chronic microglial activation: IgG complexes and immune complexes accumulate in AD brains, triggering持续 activation
- Neuroinflammation: Receptor activation leads to pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6)
- Amyloid clearance: Paradoxically, FcγRI-mediated phagocytosis may help clear amyloid plaques
- Therapeutic targeting: Fc fragment engineering can modulate microglial activation
Parkinson's Disease
In Parkinson's disease, FcγRI involvement includes:
- Activated microglia in the substantia nigra expressing FcγRI
- IgG deposition in dopaminergic [neurons](/entities/neurons)
- Potential contribution to progressive neuronal loss
- Inflammatory cascade amplification
Multiple Sclerosis
FcγRI contributes to demyelinating pathology:
- Antibody-mediated demyelination mechanisms
- Enhancement of complement-dependent cytotoxicity
- Therapeutic targeting with FcγR-blocking agents
Neuroinflammation
As a central player in CNS inflammation, FcγRI:
- Mediates cytokine storm initiation
- Activates glial cells (microglia, astrocytes)
- Links peripheral immunity to CNS responses
Signaling Pathways
FcγRI activates several downstream signaling cascades:
SYK pathway: ITAM phosphorylation → SYK recruitment → downstream activation
PI3K/Akt pathway: Cell survival and phagocytosis
MAPK pathway: Gene expression and inflammatory responses
[NF-κB](/entities/nf-kb) pathway: Pro-inflammatory cytokine transcriptionTherapeutic Implications
Drug Development
Biomarkers
- Soluble FcγRI as peripheral inflammation marker
- CSF expression levels in neurodegenerative diseases
- Microglial activation imaging targets
Animal Models
Mouse models have been instrumental in understanding FcγRI function:
- FcγRI transgenic mice: Human FcγRI expression
- Knockout studies: Loss-of-function phenotypes
- AD model crosses: Amyloid pathology modulation
Key Publications
Ravetch JV, et al. (2011). Fcγ receptors in immunity and disease. Nature Reviews Immunology. PMID: 22012441(https://pubmed.ncbi.nlm.nih.gov/22012441/)
Gong Q, et al. (2015). Microglial FcγRI in Alzheimer's disease. Journal of Neuroscience. PMID: 26424884(https://pubmed.ncbi.nlm.nih.gov/26424884/)
Nimmerjahn F, et al. (2010). FcγRIV: the high affinity receptor for IgG. Nature Reviews Immunology. PMID: 20519386(https://pubmed.ncbi.nlm.nih.gov/20519386/)See Also
- [FCGR1A Gene](/proteins/fcgr1a-protein)
- [Fc gamma receptors](/entities/fc-gamma-receptors)
- [Microglia](/entities/microglia)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Neuroimmune signaling](/mechanisms/neuroimmune-signaling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [UniProt: FCGR1A](https://www.uniprot.org/uniprot/P12314)
- [NCBI Protein: FCGR1A](https://www.ncbi.nlm.nih.gov/protein/NP_001550)
- [GeneCards: FCGR1A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FCGR1A)
Background
The study of Fcgr1A Protein Fc Gamma Receptor Ia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
- [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=FCGR1A) - View FCGR1A expression data in the human brain
- [Allen Brain Atlas API](https://api.brain-map.org/) - Programmatic access to brain atlas data
- [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental expression data
References
[Nimmerjahn A, Ravetch JV, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16356171/)
[Radermecker M, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/33329650/)
[Song W, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21389259/)